JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesIdentification of a novel human polyomavirus in organs of the gastrointestinal tractMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Progressive multifocal leukoencephalopathy: clinical and molecular aspectsIlluminating viral infections in the nervous systemFrequency and large T (LT) sequence of JC polyomavirus DNA in oligodendrocytes, astrocytes and granular cells in non-PML brain.JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.Persistence and pathogenesis of the neurotropic polyomavirus JCNovel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray areaImmunological Markers for PML Prediction in MS Patients Treated with NatalizumabJC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion productionJC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression.Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy.5-HT2 receptors facilitate JC polyomavirus entry.Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.The link between VLA-4 and JC virus reactivation.The human JC polyomavirus (JCPyV): virological background and clinical implications.Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitis.Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region.Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients.Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons.Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.Archetype JC polyomavirus prevails in a rare case of JC polyomavirus nephropathy and in stable renal transplant recipients with JC polyomavirus viruria.Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors.
P2860
Q21285083-D1F49F0F-87FA-4850-B38A-4D94276614CAQ21559678-34C849E6-E807-4DD7-9AC3-D63E4FED532FQ24619923-BC9B68E3-AD62-4955-B18F-94CA53681335Q26776236-E3850366-2730-47D7-8E33-623624122DEFQ26852060-C933DC43-D3D9-4E80-ACF3-FD310CA41EF8Q26858968-DB15FDDF-E646-43B8-A4F0-3F51E93A313AQ27310280-4D61DB20-71FB-42F4-B8C0-F62C14B7AE75Q34032491-E354CE24-3E66-4E5E-95EE-FA3994B36822Q34247539-8E0FC82E-4BF9-44D7-A79C-4434D2FAA528Q34459843-731FE7D3-A7D1-4C8D-A1E7-B10795B069B0Q34472405-FCC35C6B-5B7B-4453-8C2A-65163EEEE42FQ34818048-BB3213D8-020C-451B-A1A7-D244FDA2C1F5Q34991069-94D03FE4-158B-4D01-83B7-10DF20DDED91Q35050702-C6D41FED-41AE-4401-A562-C5C01D79B0BDQ35586120-6B40F8EB-6D53-4D4F-8FA1-4842CD054AD1Q35634870-A7638511-82E5-412B-8EEA-02BCFFDBC9A1Q35659985-5540D272-6A10-431C-B238-47E0A287CFBBQ35931809-54606774-42E1-4941-8A79-EABF08ECAD0DQ35960553-66711D2D-F156-44CA-918B-6C08AD302FDCQ36234246-3B7FD8A0-37BC-43D5-BF84-D529058C9417Q36408288-ABBC246F-7AE1-4168-977C-3984CAA06E75Q36572168-76DAA843-7C12-41A9-8BB1-A47AC34B65E7Q36827319-4264AE81-A98E-4AAF-A25A-02C209387C46Q37336799-FC9DBA9C-78F2-480E-97F2-7EEEA61F075BQ37361949-2FD5A42F-F44A-4F65-A396-1896134609FCQ37965603-BA449B5A-A688-4254-B2A6-AEF4F963A003Q38115572-7011C973-EF0B-422D-B77B-4821F2A45349Q38394692-03260CFB-E77B-4BC2-8B67-EF35DF59DF3FQ38591114-FB84A276-2212-4517-B1ED-35E41EA397A3Q38736149-BE1B0441-9E9A-4A22-8768-A17AA963F446Q39292858-00E467DD-D57A-49F9-A548-605F02B44AA7Q39322234-1E2F8694-C0EA-4C42-AB71-545DB9916141Q39451503-6D9721BD-EE21-475A-B9E5-FC55C100F8D8Q39615725-B047DCA7-AD69-4D26-953B-2392DF6EFF45Q40039520-7D031CAC-DCDD-4D70-8716-E43EF23409DAQ40222938-41E7361D-FD9C-410D-8203-3B3F43FCF4AEQ40628732-4FD16152-38E1-4A7F-8E67-BAC45CB986EDQ41509979-B7ED94E2-2273-44A3-9502-59B3AF6F6C82Q41926525-18F17E81-5DA8-4CEF-8F90-6914ECB7F250Q42188652-3A4FBD3F-17DD-4A24-8FD9-792361F70839
P2860
JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@ast
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@en
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@nl
type
label
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@ast
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@en
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@nl
prefLabel
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@ast
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@en
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@nl
P2093
P2860
P356
P1433
P1476
JC virus latency in the brain ...... ultifocal leukoencephalopathy.
@en
P2093
Chen S Tan
Christian Wüthrich
Igor J Koralnik
Janice S Miller
Jenny Saint-Aubyn
Laura C Ellis
Thomas A Broge
P2860
P304
P356
10.1128/JVI.00609-10
P407
P577
2010-07-07T00:00:00Z